Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Antibodies to myelin basic protein are associated with cognitive decline after stroke.
Herpes zoster laryngitis in a patient treated with fingolimod.
Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Employment, disability pension and income for children with parental multiple sclerosis.
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
[QUALITY OF LIFE IN CARERS OF PATIENTS WITH MULTIPLE SCLEROSIS TAKING A DISEASE-MODIFYING MEDICATION: A PILOT STUDY].
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.
Neurologic complications of immune checkpoint inhibitors.
Conditional Deletion of the L-Type Calcium Channel Cav1.2 in Oligodendrocyte Progenitor Cells Affects Postnatal Myelination in Mice.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-NO.
Opportunities and considerations for visualising neuroimaging data on very large displays.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Myelination.
MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.
Pages
« first
‹ previous
…
728
729
730
731
732
733
734
735
736
…
next ›
last »